Biocryst Pharmaceuticals Inc.

NASDAQ:BCRX  
12.37
-0.34 (-2.64%)
Mergers / Acquisitions

U.S. Government Exercises Option To Purchase Additional Rapivab From BioCryst

Published: 08/25/2022 11:31 GMT
Biocryst Pharmaceuticals Inc. (BCRX) - U.S. Government Exercises Option to Purchase Additional Rapivab® (peramivir Injection) From Biocryst for Pandemic Influenza Preparedness.
Biocryst Pharmaceuticals Inc - Proposed Deal for For Approximately $7 Million.